Quick Answer
NIKA PHARMACEUTICALS, INC reported Total Assets of $21.0 thousand for fiscal year 2025.
NIKA PHARMACEUTICALS, INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.0K | +17.1% |
| 2024 | $17.9K | -8.5% |
| 2023 | $19.6K | +2168.1% |
| 2022 | $864.00 | +116.5% |
| 2021 | $399.00 | -75.2% |
| 2020 | $1.6K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.6K | +1604.5% | -25.3% |
| June 30, 2025 | $31.6K | -91.9% | -9.7% |
| March 31, 2025 | $35.0K | -15.6% | +95.1% |
| December 31, 2024 | $17.9K | -8.5% | +1193.9% |
| September 30, 2024 | $1.4K | -87.3% | -99.6% |
| June 30, 2024 | $390.3K | +3431.4% | +841.1% |
| March 31, 2024 | $41.5K | +830.1% | +111.6% |
| December 31, 2023 | $19.6K | +2168.1% | +79.6% |
- NIKA PHARMACEUTICALS, INC showed an increase of +17.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, NIKA PHARMACEUTICALS, INC’s total assets has grown by 1203.3% (from $1.6 thousand to $21.0 thousand).
- The most recent figure is from NIKA PHARMACEUTICALS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: